静脉铁治疗降低缺铁性贫血患者的凝血倾向:一项纵向研究
本研究纳入48例缺铁性贫血(IDA)成人患者,给予静脉铁治疗,用校准自动血栓图法评估凝血倾向变化,并观察凝血因子VIII(FVIII)活性的变化。治疗后内源性凝血酶生成潜力和峰值均下降,达峰时间延长,FVIII活性降低,提示纠正缺铁可降低血液凝血倾向。
要点
- 静脉铁治疗后内源性凝血酶生成潜力平均下降122·4 nmol/l/min(95%CI:17·9-227,P=0·023)。
- 静脉铁治疗后峰值平均下降51·9(95%CI:26·6-77·2,P<0·001),达峰时间平均延长23·6秒。
- FVIII活性平均降低9·6%(95%CI:2·54-16·7,P=0·009),缺铁纠正程度与血栓图参数无相关性。
核心结论
- 缺铁性贫血经静脉铁治疗后可降低血液凝血倾向,表现为凝血酶生成和FVIII活性水平的变化。
- 未发现缺铁纠正程度与血栓图参数之间存在相关性。
研究设计与样本
- 研究纳入缺铁性贫血成人患者并给予静脉铁治疗,为纵向研究。
- 采用校准自动血栓图法评估凝血酶生成以反映凝血倾向变化。
- 随后检测FVIII活性变化,作为可能的联系环节。
- 共48例接受静脉铁治疗的患者纳入本研究。
主要发现
- 静脉铁治疗后,患者内源性凝血酶生成潜力平均下降122·4 nmol/l/min(95%CI:17·9-227,P=0·023)。
- 静脉铁治疗后,峰值平均下降51·9(95%CI:26·6-77·2,P<0·001)。
- 达峰时间平均延长23·6秒(95%CI:5·4-41·9,P=0·012)。
- FVIII活性平均降低9·6%(95%CI:2·54-16·7,P=0·009)。
- 未发现缺铁纠正程度与血栓图参数之间存在相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although many case reports and observational studies have reported a correlation between iron deficiency anaemia (IDA) and thrombotic events, the mechanism for this is poorly understood. To evaluate this, we examined the change in coagulability in patients receiving treatment for IDA. Adult patients with IDA were recruited for this study and treated with intravenous iron. The change in coagulability was assessed by thrombin generation using the calibrated automated thrombogram method. The change in factor VIII (FVIII) activity was later examined as a possible link. Forty-eight participants received intravenous iron and were included in this study. After treatment with intravenous iron, endogenous thrombin potential and peak height decreased in IDA patients by a mean of 122·4 nmol/l/min (95% confidence interval [CI]: 17·9-227, P = 0·023) and 51·9 (95% CI: 26·6-77·2, P < 0·001) respectively. Time to peak (peak time) increased by a mean of 23·6 s (95% CI: 5·4-41·9, P = 0·012). FVIII activity was reduced by a mean of 9·6% (95% CI: 2·54-16·7, P = 0·009). In conclusion, treating IDA reduces the blood's coagulability, as evidenced by the change in thrombin generation and FVIII activity levels. No correlation was found between the degree of iron deficiency correction and thrombogram parameters.
引用
- Nashashibi J, Avraham GR, Schwartz N, et al. Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study. Br J Haematol. 2019. PMID: 30681741. doi:10.1111/bjh.15765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。